BIOVISION PROGRAM

Size: px
Start display at page:

Download "BIOVISION PROGRAM"

Transcription

1 BIOVISION PROGRAM March Cité Centre de Congrès, Lyon, France Version: October In partnership with:

2 2

3 Table of contents TABLE OF CONTENTS...3 BIOVISION PARTNERS...6 PROGRAM FORMAT...7 PRELIMINARY PROGRAM...9 Decision makers perspectives... 9 Plenary 1: Health, a right for all human beings, at any price? Plenary 2: Drugs and developing countries Plenary 3: Synthetic biology: reconstructing life? Plenary 4: How will we be fed in 2020? Plenary 5: Would Pasteur and Fleming have survived the precautionary principle? Scientific Advances Health Theme 1: Brain, emotions and social behavior Theme 2: Can we cure aging? Theme 3: From systems biology to personalized medicine Theme 4: Comprehending human brain function in the future Theme 5: Cancer research for personalized patient treatment Theme 6: How to deal with emerging and re-emerging infectious diseases? Theme 7: Cell therapy: scientific, therapeutic and ethical challenges Environment Theme 8: Environment and CO Theme 9: Biofuels from Biomass Theme 10: Turn Green into Gold Nutrition Theme 11: Health, nutrition and bacteria Theme 12: More food and better food Business in science Workshop 1: How to address the volume challenge of chronic diseases in emerging countries Workshop 2: How technology will help implementing innovative healthcare delivery? Workshop 3: How to solve R&D s challenge with Open Innovation? Workshop 4: New Geography of R&D innovation in infectious and neglected diseases Social Events Gala Dinner Welcoming Night Innovation Dinner Networking Night BioVision Award

4 Governance and Organisation Steering Committee The Steering Committee approves strategic orientations and gives formal expression to links with some of BioVision s main partners. Members: Patrick Aebischer, Chairman, EPFL Ecole Polytechnique Fédérale de Lausanne (Switzerland) Gérard Collomb, Senator and Mayor of Lyon, President of the Greater Lyon Philippe Desmarescaux, Chairman and founder of BioVision Amir Dossal, Executive Director of UNOP UN Office for Partnerships (USA) Eric Froment, Chairman, Fondation Scientifique de Lyon et du Sud-Est Michel Lussault, Chairman of University of Lyon Michel Mercier, Minister for Rural Areas and Regional Planning, and Chairman of the Rhone Department General Council Alain Mérieux, Chairman, Institut Mérieux Koji Omi, Founder and Chairman of the Science and Technology in Society (STS) forum (Japan) Jacob Palis, Chairman, TWAS (The Academy of Sciences for the Developing World), (Brazil) Jean-Jack Queyranne, former minister and Chairman of the Rhone-Alps Region Ismail Serageldin, Director, Bibliotheca Alexandrina, Founder of BioVisionAlexandria (Egypt) André Syrota, Chairman, National Life Sciences and Health Alliance Elias Zerhouni, former director of NIH, Senior fellow, Bill and Melinda Gates Foundation (USA) 4

5 Scientific Committee A new international scientific committee has been established in close partnership with the Academy of Sciences. The Committee is in charge of selecting the programme themes and suggesting speakers. The Committee is responsible for the programme scientific quality and is made up of internationally recognised personalities. Chairman: Pr. François Gros, Permanent Honorary Secretary of the Academy of Sciences Members: Pr. Pascale Cossart, Research Director, Institut Pasteur, Academy of Sciences Pr. Evelyn Fox Keller, Professor, MIT (USA) Pr. Richard Frackowiak, Professor, University of Lausanne (Switzerland) Pr. Liselotte Højgaard, Professor, University of Copenhagen (Denmark) Pr. Gnissa Konate, Director, Institut de l environnement et des recherches agricoles (Burkina Faso) Pr. Philippe Kourilsky, Professor, Collège de France Pr. Jean-Marie Lehn, Professor, Collège de France, Nobel Laureate in Chemistry Pr. Pierre-Marie Lledo, Director of Research, Institut Pasteur Pr. Helga Nowotny, President, European Research Council (Austria) Pr. Michael Oborne, Director of International Futures programme, OCDE (USA) Pr. Thierry Philip, former Director of the Léon Bérard Centre Pr. Jacques Samarut, President, ENS-Lyon Pr. Philippe Sansonetti, Professor, Collège de France Pr. François Taddei, Research Director, INSERM Pr. Didier Trono, Dean of the Faculty of Life Sciences, EPFL (Switzerland) 5

6 BioVision Partners 6

7 Program Format Official language: English 3 Tracks Scientific Advances 12 themes: -7 Health -3 Environment -2 Nutrition Decision makers perspectives 6 themes - Health - Environment - Nutrition Business in science 3 themes 36 sessions 12 round tables 6 plenary sessions 3 round tables 100 speakers 30 speakers 20 speakers 150 speakers 2000 / 2500 participants

8

9 Preliminary Program Decision makers perspectives Please note that all the speakers mentioned in this document have been suggested by the Scientific Committee. Not all of them have been contacted yet. Speakers indicated in bold have accepted our invitation. Subjects and titles of sessions and talks are not final.

10 Plenary 1: Health, a right for all human beings, at any price? Co-organized with Universcience Sunday 27 March :00 to 14:30 Moderator: Pr. Helga Nowotny (President, European Research Council ERC) Introduction: Pr. Claudie Haigneré (President, Universcience) - Pr. Zhu Chen (Health Minister, China) - Pr. Michael Marmot (Director, International Institute for Society and Health University College London; Chairman, Commission on Social Determinants of Health WHO, UK) - Pr. Michel Kazatchkine (Executive Director, the Global Fund to Fight AIDS, Tuberculosis and Malaria) - Pr. Esther Duflo (Clark Medal Laureate 2010, MIT, USA) - Mr Chris Viehbacher (CEO, Sanofi-aventis) 10

11 Plenary 2: Drugs and developing countries Sunday 27 March :00 to 19:30 Moderator: Dr. Elias Zerhouni (Former Director NIH, Chair of Scientific Committee, Foundation Bill & Melinda Gates) - Mr. Hatem el Gabaly (Health Minister, Egypt) - Mr. José Angel Cordova Villalobos (Health Minister, Mexico) - Pr. Awa Marie Coll Seck (Executive Director, Roll Back Malaria, Switzerland) - Mr Alain Mérieux (Chairman, Mérieux Institute, France) - Dr. Unni Karunakara (President, Médecins sans Frontières - MSF) - Dr. Paul Stoffels (Global Head, R&D, Janssen, Pharmaceutical Companies of Johnson & Johnson) 11

12 Plenary 3: Synthetic biology: reconstructing life? Co-organized with Vivagora Monday 28 March :00 to 13:15 Moderator - Introduction: Pr. Bernadette Bensaude-Vincent (President, Vivagora) - Pr. Ada Yonath (Nobel Prize in Chemistry 2009, Israel) - Pr Jean-Marie Lehn (Nobel Prize in Chemistry 1987, France) - Pr. Edison Tak-Bun Liu (President, Human Genome Organisation - HUGO) - Mrs. Nathalie Kosciusko-Morizet (Secretary of State for Forward Planning and Development of the Digital Economy, France) Provisional agreement - Pr. Michel Serres (Philosopher, France) 12

13 Plenary 4: How will we be fed in 2020? Monday 28 March :30 to 19:00 Moderator: Mrs Maria Cattaui (Member of the Board Petroplus Holding AG, Switzerland) - Mr Antonio Tajani (European Commissioner, Industry and Entrepreneurship) - Mr. Feike Sijbesma (CEO, DSM, The Netherlands) - Mrs. Catherine Geslain-Lanéelle (Executive Director, European Food Safety Authority) - Mr. François Danel (General Director, Action Contre la Faim) - Mrs Josette Sheeran (Executive Director, World Food Programme) Invited 13

14 Plenary 5: Would Pasteur and Fleming have survived the precautionary principle? Tuesday 29 March :00 to 13:15 Moderator: Pr. Ismail Serageldin (Director, Bibliotheca Alexandrina; Professor, College de France Introduction: Pr. Philippe Kourilsky (Collège de France) - Mrs Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) provisional agreement - Pr. Mark Walport (Chief Executive Director, Wellcome Trust, UK) - Dr. Vishwa Mohan Katoch (Director, Indian Council of Medical Research, India) - Mr. Anders Olauson (President, EuropeanPatients Forum) - Dr. Thomas Lönngren (Executive Director, European Medicines Agency EMA) 14

15 15

16 16

17 Scientific Advances Health 17

18 Theme 1: Brain, emotions and social behavior Sunday 27 March :45 to 17:30 Chairperson: Pr. Pierre-Marie Lledo (Pasteur Institute, France) Scientific sessions: Learning from Others - Brain Science: a societal perspective. What is possible and what is desirable? Dr. Philip Campbell (Editor in Chief, Nature) - Stress and Depression Pr. Carmen Sandi (EPFL, Lausanne, Switzerland) - The social brain in adolescence Pr. Sarah Jayne Blakemore (Institute of Cognitive Neuroscience, University College London, London, UK) Invited Round table: When Biology meets Psychology and Social Sciences Moderator: - Dr. Snait B. Gissis (Cohn Institute, Tel Aviv University, Israel) Biological heredity and cultural inheritance - Pr. Michael Tomasello (Max Planck Institute for Evolutionary Anthropology, Germany) - Pr. Lisbeth Shepherd (Executive Director, Green City Force, Co-Founder Uniscité, New York, USA) - Mrs. Rebecca Muller (Secretary General, Global Alliance of Mental Illness Advocacy Networks GAMIAN) - Mrs Lucy Vincent (General Director, External Affairs, Servier) 18

19 Theme 2: Can we cure aging? Sunday 27 March :00 to 17:30 Chairperson: Pr. Jean-Claude Ameisen (INSERM, France) Scientific sessions: Title to be defined - A retirement home for bacteria: study and understanding of aging Pr. François Taddei (INSERM, Hôpital Necker, France) - System Biology and aging Pr. Thomas BL Kirkwood (Institute for Ageing and Health, Newcastle University, UK) - Genetics of human aging Pr. Aviv Bergman (Albert Einstein College of Medicine, New York, USA) Invited Round table: Extending life: which consequences for all of us? Moderator: Pr. Jean-Claude Ameisen - Pr. James W. Vaupel (Max Planck Institute for Demographic Research, Germany) - Pr. Miroslav Radman (INSERM, France) - Dr John Beard (Director, Department of Ageing and Life Course, WHO, Switzerland) Invited - Mr. Paul Rübig (President, Science and Technology Options Assessment STOA) Invited - Mr. Christophe Dardel (President, DSM Biomedical, The Netherlands) 19

20 Theme 3: From systems biology to personalized medicine Monday 28 March :00 to 11:45 Chairperson: Pr. Charles Auffray (European Institute for Systems Biology & Medicine) Partners: Lyonbiopôle Scientific sessions: Concepts, methods, strategies and ethics in systems biology and medicine - Combining Eastern and Western approaches of biology into systems medicine Pr. Zhu Chen (Systems Biomedicine Center, Shanghai, China) - Catalyzing the transition from reactive to proactive (P4) medicine through systems biology Pr. Lee Hood (Institute for Systems Biology, Seattle, USA) - Bioinformatics and biobanking for systems biology and medicine Pr. Anthony J. Brookes (Department of Genetics, Leicester University, UK) Round table: Defining a roadmap for systems medicine Moderator: - Pr. Sonia Abdelhak (Institut Pasteur, Tunis, Tunisia) - Pr. Jean Bousquet (INSERM, and WHO Collaborating center, Montpellier, France) - Pr. Anne Cambon-Thomsen (Genomics and Public Health, INSERM, Toulouse, France) - Pr. Denis Noble (President IUPS - Department of Anatonomy, Genetics and Physiology, Oxford University, UK) - Dr Jean-Jacques Garaud (Head of Research and Early Development, Roche) 20

21 Theme 4: Comprehending human brain function in the future Monday 28 March :30 to 17:15 Chairperson: Pr. Richard Frackowiak (University of Lausanne, Switzerland) Partner: Neurodis Scientific sessions: Harnessing modern computing to brain imaging: implications for psychology, neuroscience and neurology - Visualizing the impact of education on the brain Pr. Stanislas Dehaene (INSERM-CEA, Collège de France, France) - Predicting brain responses: The blue brain project Pr. Henry Markram (Director of the Center for Neuroscience & Technology, EPFL, Switzerland) - Industrial scale image analysis the future of neuroradiology Pr. John Mazziotta (UCLA Stroke center, LA, USA) Round table: Understanding brain function: implication for society and the future Moderator: - Pr Jean-Pierre Changeux (French Academy of Sciences, College de France, France) Invited - Pr. Helen Mayberg (Emory University, Atlanta, USA) - Pr. Wolf Singer (Max Planck Institute for Brain Research, Germany) - Pr. Alim-Louis Benabid (Scientific Advisor, CEA-Grenoble, France) - Dr Alan Gara (Blue Brain Project, IBM, USA) - Invited 21

22 Theme 5: Cancer research for personalized patient treatment Tuesday 29 March :00 to 11:45 Chairperson: Pr. Liselotte Højgaard (University of Copenhagen, Denmark) Partner: Cancéropôle CLARA Scientific sessions: Making the most of scientific achievements for a future being personalized, predictive and pre-emptive for cancer patients - New technologies for diagnosis and treatment of cancer: imaging, robotics, etc. Pr. Roger Tsien (Nobel Prize in Chemistry 2008, University of California, USA) - Targeted therapeutics, links with the genomic Pr. Jean-Yves Blay (President, European Organisation for Research and Treatment of Cancer, Leon Berard Center, France) - For the elucidation of the molecular and cellular mechanisms at the origin of certain cancers in humans. Pr. Anne Dejean-Assémat ( For Women in Science laureate, Pasteur Institute, INSERM, France) Round table: Do we implement the scientific achievements into patient treatment and pharmaceutical innovation? Moderator: - Pr. Bertrand Coiffier (European Institute of Lymphoma, University of Lyon, France) - Pr. Roger Tsien (Nobel Prize in Chemistry 2008, University of California, USA) - Mr. Robert L T Hudson (President, European Cancer Patient Coalition ECPC) Invited - Dr. Denis Lacombe (Scientific Director, European Organisation for Research and Treatment of Cancer EORTC) Invited 22

23 Theme 6: How to deal with emerging and reemerging infectious diseases? Tuesday 29 March :00 to 11:45 Chairperson: Pr. Pascale Cossart (Pasteur Institute, France) Partners: Lyonbiopôle Scientific sessions: Towards new strategies to fight emerging or re-emerging diseases - Flu, a striking example of emerging disease Pr. Yoshihiro Kawaoka (University of Wisconsin, USA) - Predisposition, genetic resistance to some infectious diseases Pr. Laurent Abel (INSERM 550, Necker Hospital, France) - New method to develop antibiotics Pr. Peter Leadlay (Cambridge University, UK) Round table: Have we considered all parameters? Moderator: - Pr. Peter Piot (Former Executive Director UNAIDS: , UK) - Pr. Françoise Barre-Sinoussi (Nobel Prize in Medicine 2008, INSERM, France) - Mrs Tran Thi Trung Chien (Former Health Minister, Vietnam) - Pr. Bruno Lina (Head, National Reference Centre for Influenza; Head, Diagnostic Virology Laboratories, University of Lyon) - Dr Peter Mueller (Executive Vice President, Global Research and Development, and Chief Scientific Officer, Vertex Pharmaceuticals, USA) - Pr. Jeffrey Almond (Head of Discovery Research and Extrernal R&D, Sanofi Pasteur, France) 23

24 Theme 7: Cell therapy: scientific, therapeutic and ethical challenges Tuesday 29 March :00 to 11:45 Chairperson: Pr. Didier Trono (EPFL, Lausanne, Switzerland) Partner: Neurodis Scientific sessions: Success and promises - The new gene therapy: a new hope Pr. Luigi Naldini (San Raffaele del Monte Tabor Foundation, Milano, Italia) - Stem cells: where are the bottlenecks? Pr Martin Evans (Nobel Prize in Medicine 2007, Cardiff University, UK) Invited - Stem cell research and regenerative medicine: a new therapy for chronic disease Pr. Alan Trounson (California Institute for Regenerative Medicine, San Francisco, USA) Round table: Societal and Ethical key issues: the citizen s rights Moderator: - Pr. Alain Fischer (INSERM, France) - Pr. Anne Cambon-Thomsen (Genomics and Public Health, INSERM, Toulouse, France) - Pr. Eva Pebay-Peyroula (President, Agence Nationale pour la Recherche; Director, Institute of Biologie Structurale, Grenoble, France) Invited - Mgr. Jacques Suaudeau (Scientific Director, Pontifical Academy for Life, Vatican) Invited - Mr. Paul Rübig (President, Science and Technology Options Assessment STOA) - Mr. Christian Béchon (CEO, LFB) 24

25 Scientific Advances Environment 25

26 Theme 8: Environment and CO2 Sunday 27 March :45 to 17:30 Chairperson: Pr. Chris Bowler (ENS Paris, France) Scientific sessions: Impacts of oceans, forests and agriculture on the carbon cycle - Carbon capture by forests Pr Simon Lewis (University of Leeds, UK) - Ocean acidification and consequences on the selection of diatoms algae Dr. Debora Iglesias-Rodriguez (School of Ocean and Earth Science University of Southampton, UK) - Reduction of nitrogen used in agriculture Pr Giles Oldroyd (John Innes Center, Norwich, UK) Round table: mitigating CO2: bio or non-bio solutions? Moderator: Pr. Chris Bowler - Pr. Victor Smetacek (Institute Alfred Wegener, Germany) - Dr Jason Clay (Senior Vice President of Market Transformation, WWF) - Dr. Ben Halpern (Project Coordinator, National Center for Ecological Analysis and Synthesis, Santa Barbara, USA) Invited 26

27 Theme 9: Biofuels from Biomass Monday 28 March :00 to 11:45 Chairperson: Pr. Bernard Bigot (CEA, France) Scientific sessions: New sources of Biofuel - Algae, fuel or feed Pr. Jonathan Gressel (TransAlgae Ltd, Israel) - Biomass conversion to biofuels and Lignocellulose enzymology Pr. Liisa Viikari (University of Helsinki, Finland) - Plant biomass utilisation Pr Keith Waldron (Institute of Food Research, Norwich, UK) Round table: What are the realistic options? Moderator: Pr. Bernard Bigot - Mrs Martina Otto (Head of policy unit, United Nations Environment Programme - UNEP) - Pr. Marion Guillou (CEO, INRA, France) Provisional agreement - Mr. Marcos Sawaya Jank (President, Brazilian Sugarcane Industry Association UNICA) Invited - Mr. Frederic Hauge (President, Bellona Foundation, Norway) - Dr Vincent Schachter (Vice-President, R&D, Total Gas and Power) 27

28 Theme 10: Turn Green into Gold Monday 28 March :30 to 17:15 Chairperson: Dr Jason Clay (Senior Vice President of Market Transformation, WWF) Scientific sessions: Biorefineries - State of the art for biorefineries Pr. Manfred Kircher (President, Board of Industrial Biotechnology Cluster CLIB2021, Germany) - Thermochemical processing of biomass - White biotechnologies Pr. Michael O Donohue (INRA, Division CEPIA, Toulouse, France) Round table: The role of Biorefinery in the Biobased Economy Moderator: Dr Jason Clay - Mrs Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) - provisional agreement - M. Rob van Leen (CIO, Royal DSM, The Netherlands) - Dr. Susan A. Mainka (Head, Science and Learning, IUCN, Switzerland) - Mr. Olivier Appert (President, Institut Français du pétrole; President, Alliance Nationale de Coordination de la Recherche pour l'énergie ANCRE) Invited 28

29 Scientific Advances Nutrition 29

30 Theme 11: Health, nutrition and bacteria Monday 28 March :00 to 11:45 Chairperson: Pr. Sven Pettersson (Karolinska Institute, Sweden) Scientific sessions: Title to be defined - Pro and prebiotics Pr. Arjan Narbad (Institute of Food research, Norwich, UK) - Interface between nutrition and signalling Pr. Walter Wahli (Centre intégratif de génomique, University of Lausanne, Switzerland) - Microflora and resistance to insulin Pr. Remy Burcelin (INSERM, Toulouse, France) Round table: Neutraceuticals: luxury niche or new hope for global nutrition? Moderator: Pr. Sven Petterson - Mrs. Catherine Geslain-Lanéelle (Executive Director, European Food Safety Authority) - Mr. José Angel Cordova Villalobos (Health Minister, Mexico) - Dr. Fernando GABILONDO (Director, Institute National de la Nutrition Mexico) - Pr. Pascale Briand (General Director for Food, French Agriculture Ministry) Provisional Agreement - Pr. Martine Laville (Director, Centre de Recherche en Nutrition Humaine CRNH, Lyon, France) 30

31 Theme 12: More food and better food Monday 28 March :30 to 17:15 Chairperson: Dr. Matthew Hills (Norwich Research Park) Partner: Norwich Research Park Scientific sessions: For more food better food - Outline the challenges facing the world in increasing crop yields and biomass Pr. Donald Ort (University of Urbana-Champaign, Illinois, USA) - New plants lower inputs Pr. Anne Osbourn (John Innes Center, Norwich, UK) - Nutritional quality of food and effects on health Pr. Cathie Martin (John Innes Center, Norwich, UK) Round table: Which new agronomy for a sustainable and productive agriculture? Moderator: Pr. Donald Ort - Pr. Marion Guillou (CEO, INRA, France) - Dr. Claudia Paoletti (Senior Scientific Officer, GMO Unit, European Food Safety Authority) - Mr. François Danel (General Director, Action Contre la Faim) - Mr. Jay Naidoo (Chairman, Global Alliance for Improved Nutrition GAIN) Invited 31

32 32

33 Business in science The end of the traditional life science industry model: What s next? Co-organized with Lyonbiopôle, France Biotech, McKinsey and Co

34 Workshop 1: How to address the volume challenge of chronic diseases in emerging countries Moderator: Introduction: TBD - Mr Antonio Tajani (European Commissioner, Industry and Entrepreneurship) - Mr. Hatem el Gabaly (Health minister, Egypt) - Dr Zeng Bing (VP, China National Pharmaceutical Group Corp, SINOPHARM) Invited - Dr. Vishwa Mohan Katoch (Director, Indian Council of Medical Research) - Mr Olivier Charmeil (Senior VP Asia/Pacific & Japan, Sanofi-aventis) 34

35 Workshop 2: How technology will help implementing innovative healthcare delivery? Moderator: Dr Olivier Raynaud (Sr Director, Health Initiatives, World Economic Forum) - Provisional agreement Introduction: TBD - Ms. Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) Provisional agreement - Ms. Nathalie Kosciusko-Morizet (Secretary of State for Forward Planning and Development of the Digital Economy) Provisional agreement - M Neil de Crescenzo (Sr VP and General Manager, Oracle Health Sciences) - Speaker from Cisco or Intel 35

36 Workshop 3: How to solve R&D s challenge with Open Innovation? Moderator: Dr André Choulika (President, France Biotech, France) Introduction: TBD - Pr. Lee Hood (President, Institute for Systems Biology, USA; Co-founder Amgen, Applied Biosystems, Rosetta, USA) - Pr. Michel Goldman (Executive Director, Innovative Medicine Initiative) - Dr Philippe Archinard (CEO, Transgene) - Dr Vincent Schachter (VP, R&D, Total Gas and Power) - M. Jacques Delort (VP, Prospective Strategic Initiatives, Sanofi-aventis) 36

37 Workshop 4: New Geography of R&D innovation in infectious and neglected diseases Moderator: TBD Introduction: Prof. Awa-Marie Coll Seck, Executive Director, Roll Back Malaria - Dr Johan Van Hoof, (Global Therapeutic Area Head for Infectious Diseases & Vaccines, Head of the Global Development Organization, Pharmaceuticals Group, Johnson & Johnson) - Dr. Robert Sebbag (VP, Access to Medicines, Sanofi-aventis) - Dr. Thomas Lönngren (Executive Director, EMA) - Pr. Françoise Barré-Sinoussi (Nobel Prize in Medicine 2008, Professor, Head of Unit of regulation of retroviral infections, Institut Pasteur, Paris, France) - Dr. John A. Thomson (VP, Strategic R&D Networks, Vertex Pharmaceuticals) - Speaker from Genzyme 37

38 38

39 Social Events Gala Dinner (150 VIP) Sunday 27 March 2011 Seizing Nature s opportunities would be good Mrs Julia Marton-Lefèvre (Director General, IUCN, Switzerland) Welcoming Night (all participants) Sunday 27 March 2011 Innovation Dinner (150 VIP) Monday 28 March 2011 Biology inspires leaders and creators (to be confirmed) Networking Night (all participants) Monday 28 March 2011 BioVision Award Tuesday 29 March

40 CONTACT INFORMATION : Fondation Scientifique de Lyon BioVision avenue Jean Jaurès Lyon T : +33 (0) F : +33 (0) biovision@biovision.org Avec le soutien de : 40

41 BIOVISION PROGRAM March Cité Centre de Congrès, Lyon, France Version: October In partnership with:

42 2

43 Table of contents TABLE OF CONTENTS...3 BIOVISION PARTNERS...6 PROGRAM FORMAT...7 PRELIMINARY PROGRAM...9 Decision makers perspectives... 9 Plenary 1: Health, a right for all human beings, at any price? Plenary 2: Drugs and developing countries Plenary 3: Synthetic biology: reconstructing life? Plenary 4: How will we be fed in 2020? Plenary 5: Would Pasteur and Fleming have survived the precautionary principle? Scientific Advances Health Theme 1: Brain, emotions and social behavior Theme 2: Can we cure aging? Theme 3: From systems biology to personalized medicine Theme 4: Comprehending human brain function in the future Theme 5: Cancer research for personalized patient treatment Theme 6: How to deal with emerging and re-emerging infectious diseases? Theme 7: Cell therapy: scientific, therapeutic and ethical challenges Environment Theme 8: Environment and CO Theme 9: Biofuels from Biomass Theme 10: Turn Green into Gold Nutrition Theme 11: Health, nutrition and bacteria Theme 12: More food and better food Business in science Workshop 1: How to address the volume challenge of chronic diseases in emerging countries Workshop 2: How technology will help implementing innovative healthcare delivery? Workshop 3: How to solve R&D s challenge with Open Innovation? Workshop 4: New Geography of R&D innovation in infectious and neglected diseases Social Events Gala Dinner Welcoming Night Innovation Dinner Networking Night BioVision Award

44 Governance and Organisation Steering Committee The Steering Committee approves strategic orientations and gives formal expression to links with some of BioVision s main partners. Members: Patrick Aebischer, Chairman, EPFL Ecole Polytechnique Fédérale de Lausanne (Switzerland) Gérard Collomb, Senator and Mayor of Lyon, President of the Greater Lyon Philippe Desmarescaux, Chairman and founder of BioVision Amir Dossal, Executive Director of UNOP UN Office for Partnerships (USA) Eric Froment, Chairman, Fondation Scientifique de Lyon et du Sud-Est Michel Lussault, Chairman of University of Lyon Michel Mercier, Minister for Rural Areas and Regional Planning, and Chairman of the Rhone Department General Council Alain Mérieux, Chairman, Institut Mérieux Koji Omi, Founder and Chairman of the Science and Technology in Society (STS) forum (Japan) Jacob Palis, Chairman, TWAS (The Academy of Sciences for the Developing World), (Brazil) Jean-Jack Queyranne, former minister and Chairman of the Rhone-Alps Region Ismail Serageldin, Director, Bibliotheca Alexandrina, Founder of BioVisionAlexandria (Egypt) André Syrota, Chairman, National Life Sciences and Health Alliance Elias Zerhouni, former director of NIH, Senior fellow, Bill and Melinda Gates Foundation (USA) 4

45 Scientific Committee A new international scientific committee has been established in close partnership with the Academy of Sciences. The Committee is in charge of selecting the programme themes and suggesting speakers. The Committee is responsible for the programme scientific quality and is made up of internationally recognised personalities. Chairman: Pr. François Gros, Permanent Honorary Secretary of the Academy of Sciences Members: Pr. Pascale Cossart, Research Director, Institut Pasteur, Academy of Sciences Pr. Evelyn Fox Keller, Professor, MIT (USA) Pr. Richard Frackowiak, Professor, University of Lausanne (Switzerland) Pr. Liselotte Højgaard, Professor, University of Copenhagen (Denmark) Pr. Gnissa Konate, Director, Institut de l environnement et des recherches agricoles (Burkina Faso) Pr. Philippe Kourilsky, Professor, Collège de France Pr. Jean-Marie Lehn, Professor, Collège de France, Nobel Laureate in Chemistry Pr. Pierre-Marie Lledo, Director of Research, Institut Pasteur Pr. Helga Nowotny, President, European Research Council (Austria) Pr. Michael Oborne, Director of International Futures programme, OCDE (USA) Pr. Thierry Philip, former Director of the Léon Bérard Centre Pr. Jacques Samarut, President, ENS-Lyon Pr. Philippe Sansonetti, Professor, Collège de France Pr. François Taddei, Research Director, INSERM Pr. Didier Trono, Dean of the Faculty of Life Sciences, EPFL (Switzerland) 5

46 BioVision Partners 6

47 Program Format Official language: English 3 Tracks Scientific Advances 12 themes: -7 Health -3 Environment -2 Nutrition Decision makers perspectives 6 themes - Health - Environment - Nutrition Business in science 3 themes 36 sessions 12 round tables 6 plenary sessions 3 round tables 100 speakers 30 speakers 20 speakers 150 speakers 2000 / 2500 participants

48

49 Preliminary Program Decision makers perspectives Please note that all the speakers mentioned in this document have been suggested by the Scientific Committee. Not all of them have been contacted yet. Speakers indicated in bold have accepted our invitation. Subjects and titles of sessions and talks are not final.

50 Plenary 1: Health, a right for all human beings, at any price? Co-organized with Universcience Sunday 27 March :00 to 14:30 Moderator: Pr. Helga Nowotny (President, European Research Council ERC) Introduction: Pr. Claudie Haigneré (President, Universcience) - Pr. Zhu Chen (Health Minister, China) - Pr. Michael Marmot (Director, International Institute for Society and Health University College London; Chairman, Commission on Social Determinants of Health WHO, UK) - Pr. Michel Kazatchkine (Executive Director, the Global Fund to Fight AIDS, Tuberculosis and Malaria) - Pr. Esther Duflo (Clark Medal Laureate 2010, MIT, USA) - Mr Chris Viehbacher (CEO, Sanofi-aventis) 10

51 Plenary 2: Drugs and developing countries Sunday 27 March :00 to 19:30 Moderator: Dr. Elias Zerhouni (Former Director NIH, Chair of Scientific Committee, Foundation Bill & Melinda Gates) - Mr. Hatem el Gabaly (Health Minister, Egypt) - Mr. José Angel Cordova Villalobos (Health Minister, Mexico) - Pr. Awa Marie Coll Seck (Executive Director, Roll Back Malaria, Switzerland) - Mr Alain Mérieux (Chairman, Mérieux Institute, France) - Dr. Unni Karunakara (President, Médecins sans Frontières - MSF) - Dr. Paul Stoffels (Global Head, R&D, Janssen, Pharmaceutical Companies of Johnson & Johnson) 11

52 Plenary 3: Synthetic biology: reconstructing life? Co-organized with Vivagora Monday 28 March :00 to 13:15 Moderator - Introduction: Pr. Bernadette Bensaude-Vincent (President, Vivagora) - Pr. Ada Yonath (Nobel Prize in Chemistry 2009, Israel) - Pr Jean-Marie Lehn (Nobel Prize in Chemistry 1987, France) - Pr. Edison Tak-Bun Liu (President, Human Genome Organisation - HUGO) - Mrs. Nathalie Kosciusko-Morizet (Secretary of State for Forward Planning and Development of the Digital Economy, France) Provisional agreement - Pr. Michel Serres (Philosopher, France) 12

53 Plenary 4: How will we be fed in 2020? Monday 28 March :30 to 19:00 Moderator: Mrs Maria Cattaui (Member of the Board Petroplus Holding AG, Switzerland) - Mr Antonio Tajani (European Commissioner, Industry and Entrepreneurship) - Mr. Feike Sijbesma (CEO, DSM, The Netherlands) - Mrs. Catherine Geslain-Lanéelle (Executive Director, European Food Safety Authority) - Mr. François Danel (General Director, Action Contre la Faim) - Mrs Josette Sheeran (Executive Director, World Food Programme) Invited 13

54 Plenary 5: Would Pasteur and Fleming have survived the precautionary principle? Tuesday 29 March :00 to 13:15 Moderator: Pr. Ismail Serageldin (Director, Bibliotheca Alexandrina; Professor, College de France Introduction: Pr. Philippe Kourilsky (Collège de France) - Mrs Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) provisional agreement - Pr. Mark Walport (Chief Executive Director, Wellcome Trust, UK) - Dr. Vishwa Mohan Katoch (Director, Indian Council of Medical Research, India) - Mr. Anders Olauson (President, EuropeanPatients Forum) - Dr. Thomas Lönngren (Executive Director, European Medicines Agency EMA) 14

55 15

56 16

57 Scientific Advances Health 17

58 Theme 1: Brain, emotions and social behavior Sunday 27 March :45 to 17:30 Chairperson: Pr. Pierre-Marie Lledo (Pasteur Institute, France) Scientific sessions: Learning from Others - Brain Science: a societal perspective. What is possible and what is desirable? Dr. Philip Campbell (Editor in Chief, Nature) - Stress and Depression Pr. Carmen Sandi (EPFL, Lausanne, Switzerland) - The social brain in adolescence Pr. Sarah Jayne Blakemore (Institute of Cognitive Neuroscience, University College London, London, UK) Invited Round table: When Biology meets Psychology and Social Sciences Moderator: - Dr. Snait B. Gissis (Cohn Institute, Tel Aviv University, Israel) Biological heredity and cultural inheritance - Pr. Michael Tomasello (Max Planck Institute for Evolutionary Anthropology, Germany) - Pr. Lisbeth Shepherd (Executive Director, Green City Force, Co-Founder Uniscité, New York, USA) - Mrs. Rebecca Muller (Secretary General, Global Alliance of Mental Illness Advocacy Networks GAMIAN) - Mrs Lucy Vincent (General Director, External Affairs, Servier) 18

59 Theme 2: Can we cure aging? Sunday 27 March :00 to 17:30 Chairperson: Pr. Jean-Claude Ameisen (INSERM, France) Scientific sessions: Title to be defined - A retirement home for bacteria: study and understanding of aging Pr. François Taddei (INSERM, Hôpital Necker, France) - System Biology and aging Pr. Thomas BL Kirkwood (Institute for Ageing and Health, Newcastle University, UK) - Genetics of human aging Pr. Aviv Bergman (Albert Einstein College of Medicine, New York, USA) Invited Round table: Extending life: which consequences for all of us? Moderator: Pr. Jean-Claude Ameisen - Pr. James W. Vaupel (Max Planck Institute for Demographic Research, Germany) - Pr. Miroslav Radman (INSERM, France) - Dr John Beard (Director, Department of Ageing and Life Course, WHO, Switzerland) Invited - Mr. Paul Rübig (President, Science and Technology Options Assessment STOA) Invited - Mr. Christophe Dardel (President, DSM Biomedical, The Netherlands) 19

60 Theme 3: From systems biology to personalized medicine Monday 28 March :00 to 11:45 Chairperson: Pr. Charles Auffray (European Institute for Systems Biology & Medicine) Partners: Lyonbiopôle Scientific sessions: Concepts, methods, strategies and ethics in systems biology and medicine - Combining Eastern and Western approaches of biology into systems medicine Pr. Zhu Chen (Systems Biomedicine Center, Shanghai, China) - Catalyzing the transition from reactive to proactive (P4) medicine through systems biology Pr. Lee Hood (Institute for Systems Biology, Seattle, USA) - Bioinformatics and biobanking for systems biology and medicine Pr. Anthony J. Brookes (Department of Genetics, Leicester University, UK) Round table: Defining a roadmap for systems medicine Moderator: - Pr. Sonia Abdelhak (Institut Pasteur, Tunis, Tunisia) - Pr. Jean Bousquet (INSERM, and WHO Collaborating center, Montpellier, France) - Pr. Anne Cambon-Thomsen (Genomics and Public Health, INSERM, Toulouse, France) - Pr. Denis Noble (President IUPS - Department of Anatonomy, Genetics and Physiology, Oxford University, UK) - Dr Jean-Jacques Garaud (Head of Research and Early Development, Roche) 20

61 Theme 4: Comprehending human brain function in the future Monday 28 March :30 to 17:15 Chairperson: Pr. Richard Frackowiak (University of Lausanne, Switzerland) Partner: Neurodis Scientific sessions: Harnessing modern computing to brain imaging: implications for psychology, neuroscience and neurology - Visualizing the impact of education on the brain Pr. Stanislas Dehaene (INSERM-CEA, Collège de France, France) - Predicting brain responses: The blue brain project Pr. Henry Markram (Director of the Center for Neuroscience & Technology, EPFL, Switzerland) - Industrial scale image analysis the future of neuroradiology Pr. John Mazziotta (UCLA Stroke center, LA, USA) Round table: Understanding brain function: implication for society and the future Moderator: - Pr Jean-Pierre Changeux (French Academy of Sciences, College de France, France) Invited - Pr. Helen Mayberg (Emory University, Atlanta, USA) - Pr. Wolf Singer (Max Planck Institute for Brain Research, Germany) - Pr. Alim-Louis Benabid (Scientific Advisor, CEA-Grenoble, France) - Dr Alan Gara (Blue Brain Project, IBM, USA) - Invited 21

62 Theme 5: Cancer research for personalized patient treatment Tuesday 29 March :00 to 11:45 Chairperson: Pr. Liselotte Højgaard (University of Copenhagen, Denmark) Partner: Cancéropôle CLARA Scientific sessions: Making the most of scientific achievements for a future being personalized, predictive and pre-emptive for cancer patients - New technologies for diagnosis and treatment of cancer: imaging, robotics, etc. Pr. Roger Tsien (Nobel Prize in Chemistry 2008, University of California, USA) - Targeted therapeutics, links with the genomic Pr. Jean-Yves Blay (President, European Organisation for Research and Treatment of Cancer, Leon Berard Center, France) - For the elucidation of the molecular and cellular mechanisms at the origin of certain cancers in humans. Pr. Anne Dejean-Assémat ( For Women in Science laureate, Pasteur Institute, INSERM, France) Round table: Do we implement the scientific achievements into patient treatment and pharmaceutical innovation? Moderator: - Pr. Bertrand Coiffier (European Institute of Lymphoma, University of Lyon, France) - Pr. Roger Tsien (Nobel Prize in Chemistry 2008, University of California, USA) - Mr. Robert L T Hudson (President, European Cancer Patient Coalition ECPC) Invited - Dr. Denis Lacombe (Scientific Director, European Organisation for Research and Treatment of Cancer EORTC) Invited 22

63 Theme 6: How to deal with emerging and reemerging infectious diseases? Tuesday 29 March :00 to 11:45 Chairperson: Pr. Pascale Cossart (Pasteur Institute, France) Partners: Lyonbiopôle Scientific sessions: Towards new strategies to fight emerging or re-emerging diseases - Flu, a striking example of emerging disease Pr. Yoshihiro Kawaoka (University of Wisconsin, USA) - Predisposition, genetic resistance to some infectious diseases Pr. Laurent Abel (INSERM 550, Necker Hospital, France) - New method to develop antibiotics Pr. Peter Leadlay (Cambridge University, UK) Round table: Have we considered all parameters? Moderator: - Pr. Peter Piot (Former Executive Director UNAIDS: , UK) - Pr. Françoise Barre-Sinoussi (Nobel Prize in Medicine 2008, INSERM, France) - Mrs Tran Thi Trung Chien (Former Health Minister, Vietnam) - Pr. Bruno Lina (Head, National Reference Centre for Influenza; Head, Diagnostic Virology Laboratories, University of Lyon) - Dr Peter Mueller (Executive Vice President, Global Research and Development, and Chief Scientific Officer, Vertex Pharmaceuticals, USA) - Pr. Jeffrey Almond (Head of Discovery Research and Extrernal R&D, Sanofi Pasteur, France) 23

64 Theme 7: Cell therapy: scientific, therapeutic and ethical challenges Tuesday 29 March :00 to 11:45 Chairperson: Pr. Didier Trono (EPFL, Lausanne, Switzerland) Partner: Neurodis Scientific sessions: Success and promises - The new gene therapy: a new hope Pr. Luigi Naldini (San Raffaele del Monte Tabor Foundation, Milano, Italia) - Stem cells: where are the bottlenecks? Pr Martin Evans (Nobel Prize in Medicine 2007, Cardiff University, UK) Invited - Stem cell research and regenerative medicine: a new therapy for chronic disease Pr. Alan Trounson (California Institute for Regenerative Medicine, San Francisco, USA) Round table: Societal and Ethical key issues: the citizen s rights Moderator: - Pr. Alain Fischer (INSERM, France) - Pr. Anne Cambon-Thomsen (Genomics and Public Health, INSERM, Toulouse, France) - Pr. Eva Pebay-Peyroula (President, Agence Nationale pour la Recherche; Director, Institute of Biologie Structurale, Grenoble, France) Invited - Mgr. Jacques Suaudeau (Scientific Director, Pontifical Academy for Life, Vatican) Invited - Mr. Paul Rübig (President, Science and Technology Options Assessment STOA) - Mr. Christian Béchon (CEO, LFB) 24

65 Scientific Advances Environment 25

66 Theme 8: Environment and CO2 Sunday 27 March :45 to 17:30 Chairperson: Pr. Chris Bowler (ENS Paris, France) Scientific sessions: Impacts of oceans, forests and agriculture on the carbon cycle - Carbon capture by forests Pr Simon Lewis (University of Leeds, UK) - Ocean acidification and consequences on the selection of diatoms algae Dr. Debora Iglesias-Rodriguez (School of Ocean and Earth Science University of Southampton, UK) - Reduction of nitrogen used in agriculture Pr Giles Oldroyd (John Innes Center, Norwich, UK) Round table: mitigating CO2: bio or non-bio solutions? Moderator: Pr. Chris Bowler - Pr. Victor Smetacek (Institute Alfred Wegener, Germany) - Dr Jason Clay (Senior Vice President of Market Transformation, WWF) - Dr. Ben Halpern (Project Coordinator, National Center for Ecological Analysis and Synthesis, Santa Barbara, USA) Invited 26

67 Theme 9: Biofuels from Biomass Monday 28 March :00 to 11:45 Chairperson: Pr. Bernard Bigot (CEA, France) Scientific sessions: New sources of Biofuel - Algae, fuel or feed Pr. Jonathan Gressel (TransAlgae Ltd, Israel) - Biomass conversion to biofuels and Lignocellulose enzymology Pr. Liisa Viikari (University of Helsinki, Finland) - Plant biomass utilisation Pr Keith Waldron (Institute of Food Research, Norwich, UK) Round table: What are the realistic options? Moderator: Pr. Bernard Bigot - Mrs Martina Otto (Head of policy unit, United Nations Environment Programme - UNEP) - Pr. Marion Guillou (CEO, INRA, France) Provisional agreement - Mr. Marcos Sawaya Jank (President, Brazilian Sugarcane Industry Association UNICA) Invited - Mr. Frederic Hauge (President, Bellona Foundation, Norway) - Dr Vincent Schachter (Vice-President, R&D, Total Gas and Power) 27

68 Theme 10: Turn Green into Gold Monday 28 March :30 to 17:15 Chairperson: Dr Jason Clay (Senior Vice President of Market Transformation, WWF) Scientific sessions: Biorefineries - State of the art for biorefineries Pr. Manfred Kircher (President, Board of Industrial Biotechnology Cluster CLIB2021, Germany) - Thermochemical processing of biomass - White biotechnologies Pr. Michael O Donohue (INRA, Division CEPIA, Toulouse, France) Round table: The role of Biorefinery in the Biobased Economy Moderator: Dr Jason Clay - Mrs Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) - provisional agreement - M. Rob van Leen (CIO, Royal DSM, The Netherlands) - Dr. Susan A. Mainka (Head, Science and Learning, IUCN, Switzerland) - Mr. Olivier Appert (President, Institut Français du pétrole; President, Alliance Nationale de Coordination de la Recherche pour l'énergie ANCRE) Invited 28

69 Scientific Advances Nutrition 29

70 Theme 11: Health, nutrition and bacteria Monday 28 March :00 to 11:45 Chairperson: Pr. Sven Pettersson (Karolinska Institute, Sweden) Scientific sessions: Title to be defined - Pro and prebiotics Pr. Arjan Narbad (Institute of Food research, Norwich, UK) - Interface between nutrition and signalling Pr. Walter Wahli (Centre intégratif de génomique, University of Lausanne, Switzerland) - Microflora and resistance to insulin Pr. Remy Burcelin (INSERM, Toulouse, France) Round table: Neutraceuticals: luxury niche or new hope for global nutrition? Moderator: Pr. Sven Petterson - Mrs. Catherine Geslain-Lanéelle (Executive Director, European Food Safety Authority) - Mr. José Angel Cordova Villalobos (Health Minister, Mexico) - Dr. Fernando GABILONDO (Director, Institute National de la Nutrition Mexico) - Pr. Pascale Briand (General Director for Food, French Agriculture Ministry) Provisional Agreement - Pr. Martine Laville (Director, Centre de Recherche en Nutrition Humaine CRNH, Lyon, France) 30

71 Theme 12: More food and better food Monday 28 March :30 to 17:15 Chairperson: Dr. Matthew Hills (Norwich Research Park) Partner: Norwich Research Park Scientific sessions: For more food better food - Outline the challenges facing the world in increasing crop yields and biomass Pr. Donald Ort (University of Urbana-Champaign, Illinois, USA) - New plants lower inputs Pr. Anne Osbourn (John Innes Center, Norwich, UK) - Nutritional quality of food and effects on health Pr. Cathie Martin (John Innes Center, Norwich, UK) Round table: Which new agronomy for a sustainable and productive agriculture? Moderator: Pr. Donald Ort - Pr. Marion Guillou (CEO, INRA, France) - Dr. Claudia Paoletti (Senior Scientific Officer, GMO Unit, European Food Safety Authority) - Mr. François Danel (General Director, Action Contre la Faim) - Mr. Jay Naidoo (Chairman, Global Alliance for Improved Nutrition GAIN) Invited 31

72 32

73 Business in science The end of the traditional life science industry model: What s next? Co-organized with Lyonbiopôle, France Biotech, McKinsey and Co

74 Workshop 1: How to address the volume challenge of chronic diseases in emerging countries Moderator: Introduction: TBD - Mr Antonio Tajani (European Commissioner, Industry and Entrepreneurship) - Mr. Hatem el Gabaly (Health minister, Egypt) - Dr Zeng Bing (VP, China National Pharmaceutical Group Corp, SINOPHARM) Invited - Dr. Vishwa Mohan Katoch (Director, Indian Council of Medical Research) - Mr Olivier Charmeil (Senior VP Asia/Pacific & Japan, Sanofi-aventis) 34

75 Workshop 2: How technology will help implementing innovative healthcare delivery? Moderator: Dr Olivier Raynaud (Sr Director, Health Initiatives, World Economic Forum) - Provisional agreement Introduction: TBD - Ms. Maire Geoghegan-Quinn (European Commissioner, Research, Innovation and Science) Provisional agreement - Ms. Nathalie Kosciusko-Morizet (Secretary of State for Forward Planning and Development of the Digital Economy) Provisional agreement - M Neil de Crescenzo (Sr VP and General Manager, Oracle Health Sciences) - Speaker from Cisco or Intel 35

76 Workshop 3: How to solve R&D s challenge with Open Innovation? Moderator: Dr André Choulika (President, France Biotech, France) Introduction: TBD - Pr. Lee Hood (President, Institute for Systems Biology, USA; Co-founder Amgen, Applied Biosystems, Rosetta, USA) - Pr. Michel Goldman (Executive Director, Innovative Medicine Initiative) - Dr Philippe Archinard (CEO, Transgene) - Dr Vincent Schachter (VP, R&D, Total Gas and Power) - M. Jacques Delort (VP, Prospective Strategic Initiatives, Sanofi-aventis) 36

77 Workshop 4: New Geography of R&D innovation in infectious and neglected diseases Moderator: TBD Introduction: Prof. Awa-Marie Coll Seck, Executive Director, Roll Back Malaria - Dr Johan Van Hoof, (Global Therapeutic Area Head for Infectious Diseases & Vaccines, Head of the Global Development Organization, Pharmaceuticals Group, Johnson & Johnson) - Dr. Robert Sebbag (VP, Access to Medicines, Sanofi-aventis) - Dr. Thomas Lönngren (Executive Director, EMA) - Pr. Françoise Barré-Sinoussi (Nobel Prize in Medicine 2008, Professor, Head of Unit of regulation of retroviral infections, Institut Pasteur, Paris, France) - Dr. John A. Thomson (VP, Strategic R&D Networks, Vertex Pharmaceuticals) - Speaker from Genzyme 37

78 38

79 Social Events Gala Dinner (150 VIP) Sunday 27 March 2011 Seizing Nature s opportunities would be good Mrs Julia Marton-Lefèvre (Director General, IUCN, Switzerland) Welcoming Night (all participants) Sunday 27 March 2011 Innovation Dinner (150 VIP) Monday 28 March 2011 Biology inspires leaders and creators (to be confirmed) Networking Night (all participants) Monday 28 March 2011 BioVision Award Tuesday 29 March

80 CONTACT INFORMATION : Fondation Scientifique de Lyon BioVision avenue Jean Jaurès Lyon T : +33 (0) F : +33 (0) biovision@biovision.org Avec le soutien de : 40

Nutrition Forum. World Food Programme & City of Rome. 31 May & 1 June 2010

Nutrition Forum. World Food Programme & City of Rome. 31 May & 1 June 2010 Nutrition Forum World Food Programme & City of Rome 31 May & 1 June 2010 The World Food Programme (WFP) has recently established a partnership with the City of Rome to raise awareness and build support

More information

Navigating the Manufacturing Process and Assuring the Quality of Regenerative Medicine Therapies A Workshop

Navigating the Manufacturing Process and Assuring the Quality of Regenerative Medicine Therapies A Workshop The Forum on Regenerative Medicine Navigating the Manufacturing Process and Assuring the Quality of Regenerative Medicine Therapies A Workshop June 26, 2017 National Academy of Sciences Building Lecture

More information

Preparedness for the inevitable: overcoming obstacles to a timely and effective R&D response. The WHO Blueprint Team

Preparedness for the inevitable: overcoming obstacles to a timely and effective R&D response. The WHO Blueprint Team Preparedness for the inevitable: overcoming obstacles to a timely and effective R&D response The WHO Blueprint Team Context of the Blueprint WHO Executive Board 1 (January 2015) WHO Summit on Ebola R&D

More information

October 29 - November

October 29 - November Les Pensières Veyrier-du-Lac (French Alps) October 29 - November 3 2017 Organized by The Mérieux Foundation and the London School of Hygiene & Tropical Medicine ACDx enhances the knowledge and professional

More information

System Biology and Immune Response

System Biology and Immune Response System Biology and Immune Response Fondation Mérieux Conference Centre Les Pensières Veyrier-du-Lac - France June 21-23, 2010 Steering Committee: Nicolas BURDIN Bruno GUY Michael KATZE Jacques LOUIS Ray

More information

A French Biotechnology company dedicated to the development and production of human endocrine cell lines. Innovation In Healthcare April 2012

A French Biotechnology company dedicated to the development and production of human endocrine cell lines. Innovation In Healthcare April 2012 A French Biotechnology company dedicated to the development and production of human endocrine cell lines Innovation In Healthcare 16-17 April 2012 1 French Biotechnology company Founded in S2 2004 in Paris

More information

A Forum organised by. Session 1: Smart Cities & Energy transition. Session 2: Renewables energy directive revision, what place for biofuels?

A Forum organised by. Session 1: Smart Cities & Energy transition. Session 2: Renewables energy directive revision, what place for biofuels? A Forum organised by Date 5 October 2017 time 8, 15-14, 00 Venue: Palais Bourbon Salle Victor Hugo 101 Rue de l'université, 75007 Paris, France The Clean Energy for all Europeans package of legislation

More information

OECD Workshop on Resilient Cities

OECD Workshop on Resilient Cities OECD Workshop on Resilient Cities 5-6 November, 2015 OECD Headquarters, Marshall Building 6122 2 André-Pascal, Paris, 75116 France Objectives This workshop is organised as a part of the OECD Resilient

More information

Research Xchange Forum 2018

Research Xchange Forum 2018 Research Xchange Forum 2018 Insights Translation Solutions Trends and Challenges in Regenerative Medicine & Cell Therapy March 20 21, 2018 Sartorius Goettingen, Germany What to expect Learn about the latest

More information

ATIP Avenir Program 2018 Young group leader

ATIP Avenir Program 2018 Young group leader ATIP Avenir Program 2018 Young group leader Important dates - October 17th (4 pm) 2017 : opening of the registrations online - November 23 th 2017: deadline for the online submission, the mailing of the

More information

Department of Research Evaluation. Université de Strasbourg Centre National de la Recherche Scientifique - CNRS

Department of Research Evaluation. Université de Strasbourg Centre National de la Recherche Scientifique - CNRS Department of Research Evaluation report on research unit: Architecture and Reactivity of RNA ARN under the supervision of the following institutions and research bodies: Université de Strasbourg Centre

More information

Novel tool to monitor therapeutic response. patients with viral leukemia

Novel tool to monitor therapeutic response. patients with viral leukemia Press release Novel tool to monitor therapeutic response of patients with viral leukemia Brussels, 5 September 2017 A few months after the discovery of a novel mechanism by which viruses cause leukemia

More information

Presented by: Dr. Philip Landrigan Dean for Global Health Icahn School of Medicine at Mount Sinai

Presented by: Dr. Philip Landrigan Dean for Global Health Icahn School of Medicine at Mount Sinai Presented by: Dr. Philip Landrigan Dean for Global Health Icahn School of Medicine at Mount Sinai 212.824.7046 phil.landrigan@mssm.edu Richard Fuller President Pure Earth 212.870.3490 fuller@pureearth.org

More information

Application from the World Federation of Chinese Medicine Societies for admission into official relations with WHO

Application from the World Federation of Chinese Medicine Societies for admission into official relations with WHO EXECUTIVE BOARD EB136/NGO/6 136th session 6 November 2014 Provisional agenda item 13.3 Application from the World Federation of Chinese Medicine Societies for admission into official relations with WHO

More information

Master of Science in Biotechnology Program. ms-biotech.wisc.edu November 8, 2017

Master of Science in Biotechnology Program. ms-biotech.wisc.edu November 8, 2017 Master of Science in Biotechnology Program ms-biotech.wisc.edu November 8, 2017 Program Mission: An integrated curriculum in science, policy, law and business preparing students to LEAD the development

More information

Department of Research Evaluation

Department of Research Evaluation Department of Research Evaluation report on research unit: Center of Immunology of Marseille-Luminy CIML under the supervision of the following institutions and research bodies: Aix-Marseille Université

More information

The response of research: from the field to the lab. K. Victoir PhD

The response of research: from the field to the lab. K. Victoir PhD The response of research: from the field to the lab K. Victoir PhD Outline Responses to the Ebola outbreak: a nations response (France) and an institutional response (IP) Overview of the Field actions

More information

MARIO CAPECCHI, UNIVERSITY OF UTAH GENE TARGETING PIONEER, WINS 2007 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE

MARIO CAPECCHI, UNIVERSITY OF UTAH GENE TARGETING PIONEER, WINS 2007 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE For Immediate Release October 8, 2007 Contacts: Phil Sahm, 801-581-2517 801-581-7387 Additional Lines: 801-581-5717 801-581-5148 801-585-5185 801-581-5718 801-587-7212 News Conference with Dr. Capecchi

More information

European bioregions : strengths and partnership strategies. The bioxclusters example BioPartnering Latin America cluster forum september 2013

European bioregions : strengths and partnership strategies. The bioxclusters example BioPartnering Latin America cluster forum september 2013 European bioregions : strengths and partnership strategies. The bioxclusters example BioPartnering Latin America cluster forum september 2013 Contents Who we are Our goals Our activities Wha we can offer

More information

REIMAGINING DRUG DEVELOPMENT:

REIMAGINING DRUG DEVELOPMENT: Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY

More information

Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development A Workshop

Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development A Workshop A Collaboration between the Forum on Drug Discovery, Development, and Translation and the Roundtable on Genomics and Precision Health Enabling Precision Medicine: The Role of Genetics in Clinical Drug

More information

Funding AMR research: the UK Research Councils John Savill

Funding AMR research: the UK Research Councils John Savill Funding AMR research: the UK Research Councils John Savill Medical Research Council - UK MRC mission Encourage and support high-quality research with the aim of improving human health. Produce skilled

More information

Research Xchange Forum 2018

Research Xchange Forum 2018 Research Xchange Forum 2018 Insights Translation Solutions Trends and Challenges in Regenerative Medicine & Cell Therapy March 20 21, 2018 Sartorius Goettingen, Germany What to expect Learn about the latest

More information

1. FACTS AND FIGURES, YOUR ASSET, AUDIENCE, KEYNOTE SPEAKERS

1. FACTS AND FIGURES, YOUR ASSET, AUDIENCE, KEYNOTE SPEAKERS CONTENT 1. Facts & Figures, Your Asset, Audience, Keynote speakers 4 2. Video & Quotes 8 3. Date and Location 12 4. Theme / Topics / Keynote speakers 14 5. Partner Packages 17 6. Contact About the Organizers

More information

International Conference of the Korean Society for Molecular and Cellular Biology

International Conference of the Korean Society for Molecular and Cellular Biology KSMCB The 26 th International Conference of the Korean Society for Molecular and Cellular Biology October 21 (Tue) ~ 23 (Thu), 2014 Seminar : Grand Ballroom (1F) Exhibition & Poster Presentation : Hall

More information

2014 United Nations Public Service Day, Awards Ceremony and Forum, Innovating Governance for Sustainable Development and Well-being of the People

2014 United Nations Public Service Day, Awards Ceremony and Forum, Innovating Governance for Sustainable Development and Well-being of the People 2014 United Nations Public Service Day, Awards Ceremony and Forum, Innovating Governance for Sustainable Development and Well-being of the People Agenda Korea International Exhibition Center (KINTEX) Seoul,

More information

Conference Programme. 5 Days 08:45 17:00. 2 Days 08:45 17:00 08:30 15:00

Conference Programme. 5 Days 08:45 17:00. 2 Days 08:45 17:00 08:30 15:00 Conference Programme 5 Days 08:45 17:00 2 Days 08:45 17:00 08:30 15:00 19:30 22:00 FIDIC YPMTP 2017 Young Professionals Management Training Programme Wednesday, 27 th of September Sunday, 1 st of October

More information

Research units. Institut de Recherche en Technologies et Sciences pour le Vivant irtsv

Research units. Institut de Recherche en Technologies et Sciences pour le Vivant irtsv Research units HCERES report on federative structure: Institut de Recherche en Technologies et Sciences pour le Vivant irtsv Under the supervision of the following institutions and research bodies: Université

More information

LOW CARBON CEMENT. - Supporting Sustainable Development of Emerging Economies. Agenda TIME TOPIC SPEAKER AFFILIATION.

LOW CARBON CEMENT. - Supporting Sustainable Development of Emerging Economies. Agenda TIME TOPIC SPEAKER AFFILIATION. LOW CARBON CEMENT - Supporting Sustainable Development of Emerging Economies Agenda 16 th November, 2016, Green Zone TIME TOPIC SPEAKER AFFILIATION 15.00 hrs Introduction to Side Event on Low Carbon Cement

More information

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary

More information

Microbiology and Molecular Genetics

Microbiology and Molecular Genetics University of California, Irvine 2017-2018 1 Microbiology and Molecular Genetics Rozanne M. Sandri-Goldin, Department Chair Klemens J. Hertel, Department Vice Chair Klemens J. Hertel, Departmental Graduate

More information

LSE Health Market Access Academy April 2018, London September 2018, London

LSE Health Market Access Academy April 2018, London September 2018, London LSE Health Market Access Academy 9 13 April 2018, London 10 14 September 2018, London In cooperation with the Boston Consulting Group Market Access Roundtable LSE Health Market Access Academy 2 The London

More information

Monday 13th November. Real Academia de Ingeniería (c/ Don Pedro, 10 Madrid) Time Program Topic. CAETS Executive Committee meeting

Monday 13th November. Real Academia de Ingeniería (c/ Don Pedro, 10 Madrid) Time Program Topic. CAETS Executive Committee meeting Monday 13th November Real Academia de Ingeniería (c/ Don Pedro, 10 Madrid) Time Program Topic 10:0012:00 h CAETS Executive Committee meeting 12:3014:00 h Lunch 14:3015:30 h CAETS Board of Directors meeting

More information

Department of Research Evaluation. Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion

Department of Research Evaluation. Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion Department of Research Evaluation report on research unit: Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion Under the supervision of the following institutions and research

More information

Bilateral Agreements on Cooperation in Science and Technology, and Joint Committees

Bilateral Agreements on Cooperation in Science and Technology, and Joint Committees Bilateral Agreements on Cooperation in Science and Technology, and Joint Committees Bilateral meetings Aiming to promote cooperative relationships with other countries in the field of science and technology,

More information

Options and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal

Options and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal EFGCP Workshop on Options and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal Road Map Initiative for Clinical Research in Europe Husa President Hotel, Brussels, Belgium 7 &

More information

Mechanical Engineering (n=127) PSU Acoustics

Mechanical Engineering (n=127) PSU Acoustics Mechanical Engineering (n=127) PSU Acoustics Acoustics Mechanical Engineering Aerospace Engineering (n=31) PSU Aerospace Engineering 0 5 10 15 20 25 30 Aerospace Engineering Aerospace Engineering 0 5 10

More information

MASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY. Faculty of Medicine and Surgery

MASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY. Faculty of Medicine and Surgery MASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY Faculty of Medicine and Surgery PRESENTATION This 2-Year Master s Degree in Biotechnology and Medical Biology bridges theoretical knowledge to hands-on

More information

Productivity, Jobs, Wellbeing: Making Infrastructure Deliver

Productivity, Jobs, Wellbeing: Making Infrastructure Deliver 2nd OECD Forum on Governance of Infrastructure Productivity, Jobs, Wellbeing: Making Infrastructure Deliver OECD, Paris, 20 March 2017 Agenda Productivity, jobs, wellbeing: making infrastructure deliver

More information

Roche in Australia Innovation Leader

Roche in Australia Innovation Leader Roche in Australia Innovation Leader About Roche Innovation: it s in our DNA 7,000,874 hours of work 6,587 experiments 423 researchers 1 drug For nearly 120 years, Roche has been committed to improving

More information

Monday, March 10, Tuesday, March 11, :00 p.m. 10:00 p.m. Registration Open West Foyer. Welcome and Opening Reception. North & West Foyer

Monday, March 10, Tuesday, March 11, :00 p.m. 10:00 p.m. Registration Open West Foyer. Welcome and Opening Reception. North & West Foyer Monday, March 10, 2014 3:00 p.m. 10:00 p.m. Registration Open West Foyer 5:00 p.m. 7:00 p.m. Welcome and Opening Reception Exhibitor Showcase 7:00 p.m. 10:00 p.m. 80s Night Theme Dinner Aria Lawn Tuesday,

More information

NIHR at 10: Wessex. Professor Chris Whitty Chief Scientific Adviser Department of Health

NIHR at 10: Wessex. Professor Chris Whitty Chief Scientific Adviser Department of Health NIHR at 10: Wessex Professor Chris Whitty Chief Scientific Adviser Department of Health Building on 10 remarkable years The extraordinary advances in health are based on evidence and science, properly

More information

CORK 2.0 EUROPEAN CONFERENCE ON RURAL DEVELOPMENT PROGRAMME 5-6 SEPTEMBER Agriculture and Rural Development

CORK 2.0 EUROPEAN CONFERENCE ON RURAL DEVELOPMENT PROGRAMME 5-6 SEPTEMBER Agriculture and Rural Development CORK 2.0 EUROPEAN CONFERENCE ON RURAL DEVELOPMENT 5-6 SEPTEMBER 2016 PROGRAMME Agriculture and Rural Development 2 FOREWORD PAGE 3 PROGRAMME AT A GLANCE PAGES 4-5 WORKSHOPS DESCRIPTION PAGES 6-7 #EU_Cork2

More information

PATHWAYS TO SUSTAINABLE DEVELOPMENT YOUTH IN ACTION CAMPAIGNS FOR CHANGE. Programme

PATHWAYS TO SUSTAINABLE DEVELOPMENT YOUTH IN ACTION CAMPAIGNS FOR CHANGE. Programme PATHWAYS TO SUSTAINABLE DEVELOPMENT YOUTH IN ACTION CAMPAIGNS FOR CHANGE Programme INTERNATIONAL YOUTH CLIMATE WEEK IN WOLFSBURG 22.- 30. APRIL 2012 SUNDAY 22 APRIL ARRIVAL DAY MONDAY 23 APRIL 7.00 8.00

More information

Research Within Bounds

Research Within Bounds Programme University of Kent, Great Britain University of Erlangen-Nürnberg, Germany University of Neuchâtel, Switzerland Research Within Bounds Protecting Human Participants in Modern Medicine and the

More information

European Platform of Universities Engaged in Energy Research, Education and Training (EPUE) Developing the Platform: from Concept to Implementation

European Platform of Universities Engaged in Energy Research, Education and Training (EPUE) Developing the Platform: from Concept to Implementation European Platform of Universities Engaged in Energy Research, Education and Training (EPUE) Developing the Platform: from Concept to Implementation Plenary Session 2: EPUE Capacity on Research and Education

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS Q: WHAT IS HUMAN LONGEVITY INC.? A: Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

More information

Canadian Branch of the Assemblée parlementaire de la Francophonie (APF) Paris and Clermont-Ferrand, France January 21 27, 2015

Canadian Branch of the Assemblée parlementaire de la Francophonie (APF) Paris and Clermont-Ferrand, France January 21 27, 2015 Report of the Canadian Parliamentary Delegation on its participation at the Bureau Meeting of the Assemblée parlementaire de la Francophonie (APF) and a Bilateral Meeting Canadian Branch of the Assemblée

More information

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA Dr. Henry Daniell Pegasus Professor & University Board of Trustee Chair Dept. Mol.

More information

High Level Meeting on the New Urban Agenda and UN-Habitat Trusteeship Council Chamber, 5-6 September Provisional Program

High Level Meeting on the New Urban Agenda and UN-Habitat Trusteeship Council Chamber, 5-6 September Provisional Program High Level Meeting on the New Urban Agenda and UN-Habitat Trusteeship Council Chamber, 5-6 September 2017 September 5, Tuesday 10:00-10:20 Opening Segment Provisional Program - H.E. Mr. Peter Thomson President

More information

HCERES report on research unit:

HCERES report on research unit: Research units HCERES report on research unit: Centre de Recherche en Transplantation et Immunologie CRTI Under the supervision of the following institutions and research bodies: Université de Nantes Institut

More information

Applications of In Situ Hybridisation in Research and Disease

Applications of In Situ Hybridisation in Research and Disease Cancer Research UK Cambridge Institute Applications of In Situ Hybridisation in Research and Disease 7 8 May 2015 Programme Applications of In Situ Hybridisation in Research and Disease 11 Thursday 7 May

More information

innovative unrivalled committed inspirational international

innovative unrivalled committed inspirational international innovative unrivalled committed inspirational international innovative unrivalled committed inspirational WorldSkills is a powerful means for building a global skills respect culture. It enables the best

More information

Research Strategy Delivering internationally excellent research for a healthy, safe and sustainable society

Research Strategy Delivering internationally excellent research for a healthy, safe and sustainable society Research Strategy 2016-2018 Delivering internationally excellent research for a healthy, safe and sustainable society Mission The College of Biomedical and Life Sciences aims to deliver internationally

More information

ALDA General Assembly and related events

ALDA General Assembly and related events ALDA General Assembly and related events Paris, 10 th -13 th May 2016 v Tuesday 10 th May Steering Committee of LADDER Project Venue: Association des Régions de France (TBC) 09.00 12.30 Steering Committee

More information

Power for America Conference

Power for America Conference UTILITY WORKERS UNION OF AMERICA, AFL-CIO Power for America Conference April 22, 23 & 24, 2009 Bally s, Las Vegas, NV Las Vegas, NV Las Vegas, NV DRAFT AGENDA Wednesday, April 22, 2009 6:00 8:30 Registration

More information

ESGCT/ICH Workshop on Viral Vector Shedding

ESGCT/ICH Workshop on Viral Vector Shedding ESGCT/ICH Workshop on Viral Vector Shedding Introductory notes: What is vector shedding? Why is it important? Klaus Cichutek Chair, at EMEA -Institut, 63225 Langen, Germany E-mail: cickl@pei.de Rotterdam,

More information

BSc Minors in English

BSc Minors in English BSc Minors in English Wageningen University All minors presented on this information sheet are taught in English. For more information please surf to: www.wageningenuniversity.nl/minors For contact details

More information

Biological Agents Index

Biological Agents Index Biological Agents Index Risk Management Strategies for Contagions Achieving cost-effective outcomes using macroeconomics and microbiology, in addition to new public management concepts for implementation

More information

Department of Research Evaluation. Theory and Approaches of Genomics Complexity TAGC

Department of Research Evaluation. Theory and Approaches of Genomics Complexity TAGC Department of Research Evaluation report on the research unit: Theory and Approaches of Genomics Complexity TAGC under the supervision of the following institutions and research bodies: Aix-Marseille Université

More information

European Molecular Biology Laboratory

European Molecular Biology Laboratory European Molecular Biology Laboratory Laboratoire Européen de Biologie Moléculaire Europäisches Laboratorium für Molekularbiologie Prof. Iain W. Mattaj, Director General EMBL Member States Austria 1974

More information

THE CELL BIOLOGY BEHIND THE ONCOGENIC PIP3 LIPIDS

THE CELL BIOLOGY BEHIND THE ONCOGENIC PIP3 LIPIDS WORKSHOPS CURRENT TRENDS IN BIOMEDICINE 2018 SEDE ANTONIO MACHADO BAEZA, SPAIN THE CELL BIOLOGY BEHIND THE ONCOGENIC PIP3 LIPIDS Baeza, Spain 15 th -17 th October 2018 Organized by: Richard A. Anderson

More information

Subject: Invitation to the 12th Global Summit of National Ethics/Bioethics Committees

Subject: Invitation to the 12th Global Summit of National Ethics/Bioethics Committees 18/01/2018 Ref.: CL/4230 Subject: Invitation to the 12th Global Summit of National Ethics/Bioethics Committees Sir/Madam, I have the honour to invite your Government to nominate a participant to attend

More information

AGENDA. In the Public Interest: Delivery of Sustainable, Transparent and Inclusive Infrastructure. 3rd OECD Forum on Governance of Infrastructure

AGENDA. In the Public Interest: Delivery of Sustainable, Transparent and Inclusive Infrastructure. 3rd OECD Forum on Governance of Infrastructure 3rd OECD Forum on Governance of Infrastructure In the Public Interest: Delivery of Sustainable, Transparent and Inclusive Infrastructure OECD, Paris, 26 March 2018 AGENDA In partnership with: Quality Infrastructure

More information

University of Manchester and EU Funding Health & Social Care

University of Manchester and EU Funding Health & Social Care University of Manchester and EU Funding Health & Social Care 1. FP7 Overview Facts and Figures 2. Horizon 2020 Story So Far 3. Future Activities Horizon 2020 and Beyond Claire Faichnie and Liz Fay EU Funding

More information

ENERGY STUDIES. Information Session Spring Term Thursday, January 19, 2017, 4:30 pm KGL 123 MULTIDISCIPLINARY ACADEMIC PROGRAM

ENERGY STUDIES. Information Session Spring Term Thursday, January 19, 2017, 4:30 pm KGL 123 MULTIDISCIPLINARY ACADEMIC PROGRAM ENERGY STUDIES MULTIDISCIPLINARY ACADEMIC PROGRAM Information Session Spring Term 2017 Thursday, January 19, 2017, 4:30 pm KGL 123 Energy Studies Class of 2019 (36) Applied Mathematics Applied Physics

More information

Temple of pharma - Speciality Chemicals Magazine

Temple of pharma - Speciality Chemicals Magazine Page 1 of 5 Fine Chemicals Temple of pharma Dr Magid Abou-Gharbia will be bringing the insights from a distinguished career to a key panel discussion at Chemspec USA. We caught up with him at Temple University

More information

Application of Proteomics and Transcriptomics in EMF Research

Application of Proteomics and Transcriptomics in EMF Research Workshop Application of Proteomics and Transcriptomics in EMF Research October 30 - November 1, 2005 STUK- Radiation and Nuclear Safety Authority Laippatie 4, 00880 Helsinki, Finland http://www.who.int/peh-emf/meetings/proteomics_helsinki05/en/

More information

BIOSCIENCE IN THE 21 ST CENTURY: HIGHLIGHTS AND FUTURE PROSPECTS

BIOSCIENCE IN THE 21 ST CENTURY: HIGHLIGHTS AND FUTURE PROSPECTS BIOSCIENCE IN THE 21 ST CENTURY: HIGHLIGHTS AND FUTURE PROSPECTS BIOSCIENCE IN THE 21 ST CENTURY What biologically relevant problems confront society? What are the strategies for studying these problems?

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

and behavior B. Hans Frossberg, PhD I. The Journal The Institutions A. Rochellys Diaz Heijtz, PhD C. Sven Petterson, MD

and behavior B. Hans Frossberg, PhD I. The Journal The Institutions A. Rochellys Diaz Heijtz, PhD C. Sven Petterson, MD Normal gut microbiota modulates brain development and behavior Rollchellys Diaz Heijitz, Shugui Wang, Farhana Anuar, Yu Quian, Britta Bjorkholm, Annika Samuelsson, Martin L Hibberd, Hans Forssberg, and

More information

The 21st Century Cures Act

The 21st Century Cures Act The 21st Century Cures Act Published: Dec 14, 2016 By: David S. Guzick, M.D., Ph.D.Category: UF Health In recent weeks, the 21st Century Cures Act was passed overwhelmingly by both chambers of the U.S.

More information

Prospects for the International Bioenergy Market and Scientific Cooperation

Prospects for the International Bioenergy Market and Scientific Cooperation Prospects for the International Bioenergy Market and Scientific Cooperation Network of Expertise in Energy Technology Integrated Approaches to Energy Technologies Beijing, China November 27, 2012 Jonathan

More information

Building molecular handprints: a systems biology approach to complex diseases

Building molecular handprints: a systems biology approach to complex diseases Building molecular handprints: a systems biology approach to complex diseases Bertrand De Meulder, PhD EISBM, CIRI UMR5308, CNRS-ENS-UCBL-INSERM, Lyon, France SIMONCO Workshop, 27th June 2016 Phenotypes

More information

Update on Current FDA Policies and Priorities

Update on Current FDA Policies and Priorities Update on Current FDA Policies and Priorities Vernessa Pollard MassMEDIC FDA Update December 12, 2017 Boston Brussels Chicago Dallas Düsseldorf Frankfurt Houston London Los Angeles Miami Milan Munich New

More information

University of the Philippines

University of the Philippines University of the Philippines Groundbreaking of the Philippine Genome Center Building April 10, 2014 Launch of the Core Facility for Bioinformatics April 14, 2014 SCIENTIFIC SYMPOSIUM Genomics: The Path

More information

The Review Section Table (Overview)

The Review Section Table (Overview) Broad Section A Broad Section A (continued) Medium-sized Section 1:Philosophy, art, Medium-sized Section 5 :Law 01010 Philosophy and ethics-related 05010 Legal theory and history-related 01020 Chinese

More information

Department of Research Evaluation. Université de Poitiers Institut National de la Santé Et de la Recherche Médicale - INSERM

Department of Research Evaluation. Université de Poitiers Institut National de la Santé Et de la Recherche Médicale - INSERM Department of Research Evaluation Report on research unit: Pharmacology of Antimicrobial Agents PHAR under the supervision of the following institutions and research bodies: Université de Poitiers Institut

More information

EU-US US Working Group on Environmental Biotechnology

EU-US US Working Group on Environmental Biotechnology EU-US US Working Group on Environmental Biotechnology Herman van Mellaert and Jens Hoegel, EC Directorate-General for Research and Innovation Todd Anderson, US Dept. of Energy June 2012 08/11/2012 1 Working

More information

SOCIAL CAPITAL - TERRITORIAL CAPITAL : inventing new forms of strategic development for the territories of Europe

SOCIAL CAPITAL - TERRITORIAL CAPITAL : inventing new forms of strategic development for the territories of Europe SPAN, the Strategy Planning Action Network, is pleased to invite you to its second public event, to be held at the Palais des Congrès in Liège on 30 May 2007. SOCIAL CAPITAL - TERRITORIAL CAPITAL : inventing

More information

United Nations Division for Sustainable Development Goals Department of Economic and Social Affairs. Sustainable Consumption and Production (SCP)

United Nations Division for Sustainable Development Goals Department of Economic and Social Affairs. Sustainable Consumption and Production (SCP) United Nations Division for Sustainable Development Goals Department of Economic and Social Affairs Sustainable Consumption and Production (SCP) An expert group meeting 1 in preparation for the High Level

More information

High-Level Conference on Water, Climate and Health. 23 November, 2012

High-Level Conference on Water, Climate and Health. 23 November, 2012 First International Forum on Development, Environment and Health Arezzo, Italy, November 20-23, 2012 High-Level Conference on Water, Climate and Health 23 November, 2012 Organised by the Italian Ministry

More information

Biomedical Engineering for Global Health

Biomedical Engineering for Global Health Biomedical Engineering for Global Health s pioneering work and teaching are captured in this motivating text written for non-science majors and biomedical engineers, inspiring them to engage in solving

More information

Workshop Programme. 10 May 2017

Workshop Programme. 10 May 2017 Workshop Programme 10 May 2017 Kindly sponsored by Abbott Cerus Corporation DiaSorin S.p.A. GFE Blut Grifols Macopharma Roche Diagnostics Terumo BCT - Page 1 Day I - Tuesday 16 May 2017 08.45 hrs SESSION

More information

ATIP Avenir Program 2018 Young group leader. Guide for applicants

ATIP Avenir Program 2018 Young group leader. Guide for applicants ATIP Avenir Program 2018 Young group leader Guide for applicants Important dates - November 23 rd 2017: deadline for the online submission, the mailing of the hard copy of the scientific project, and the

More information

HCERES report on research unit:

HCERES report on research unit: Research units HCERES report on research unit: Thérapeutiques Cliniques et Expérimentales des Infections Under the supervision of the following institutions and research bodies: Université de Nantes Evaluation

More information

Summer Institute Program

Summer Institute Program Summer Institute Program Micro and Nanotechnology Laboratory (MNTL) University of Illinois at Urbana-Champaign 208 N. Wright Street, Urbana, IL 61801 Phone: 217-333-3097 and 217-244-1353 The overall objective

More information

Rare diseases in the 7th EU Framework Programme for Research and Technological Development

Rare diseases in the 7th EU Framework Programme for Research and Technological Development Rare diseases in the 7th EU Framework Programme for Research and Technological Development Manuel Hallen, MD Head of Unit Medical & Public Health Research DG Research European Commission 1 The role of

More information

AG RESEARCH AT PURDUE. People. Making an Impact

AG RESEARCH AT PURDUE. People. Making an Impact AG RESEARCH AT PURDUE People Making an Impact BUILD UTILIZE DEVELOP ENHANCE STRENGTHEN FACILITATE urdue Agriculture is people talented faculty, dedicated staff, and motivated students who grow into an

More information

It s in Lyon...and it s Not a Coincidence

It s in Lyon...and it s Not a Coincidence Lyon, 31st October, 2008 It s in Lyon...and it s Not a Coincidence Lyon, an International Metropolis Lyon, a Human-Scale International Metropolis Lyon and its region : key figures #2 region in France Population

More information

BIOMEDICAL RESEARCH CENTRES

BIOMEDICAL RESEARCH CENTRES Introduction BIOMEDICAL RESEARCH CENTRES The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the

More information

TransCelerate BioPharma, Inc. Clinical Data Standards Project. Dave Jordan Data Standards Project Leader

TransCelerate BioPharma, Inc. Clinical Data Standards Project. Dave Jordan Data Standards Project Leader TransCelerate BioPharma, Inc. Clinical Data Standards Project Dave Jordan Data Standards Project Leader 1 Outline TransCelerate Overview CFAST Overview Therapeutic Area Standards Project CDISC SHARE Q

More information

Course Descriptions. BIOL: Biology. MICB: Microbiology. [1]

Course Descriptions. BIOL: Biology. MICB: Microbiology.  [1] Course Descriptions BIOL: Biology http://www.calendar.ubc.ca/vancouver/courses.cfm?code=biol [1] BIOL 112 (3) Biology of the Cell The principles of cellular and molecular biology using bacterial and eukaryotic

More information

High Profile Publishing in Molecular Biology. Hélène Hodak, Marina Ostankovitch,

High Profile Publishing in Molecular Biology. Hélène Hodak, Marina Ostankovitch, High Profile Publishing in Molecular Biology Hélène Hodak, h.hodak@elsevier.com Marina Ostankovitch, m.ostankovitch@elsevier.com The field of Molecular Biology, inception to current trends Preparing a

More information

INTERNATIONAL COLLABORATION. S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India

INTERNATIONAL COLLABORATION. S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India INTERNATIONAL COLLABORATION S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India INDIA S ASSETS Strong pool of scientists and engineers >300,000 institutions

More information

Alps Bio Cluster Biotech and medtech in Alpine Space

Alps Bio Cluster Biotech and medtech in Alpine Space VIIth European Mountain Conference, 15th-17th September 2010, Lillehammer, Norway Alps Bio Cluster Biotech and medtech in Alpine Space www.alpsbiocluster.eu Alpine Space programme European territorial

More information

International Gas Union

International Gas Union International Gas Union 2014 About IGU Serves as spokesperson for the gas industry (since 1931) Promotes political, technical & economic progress of the gas industry Emphasises sound environmental performance

More information

Mechanical Engineering (n=127) PSU Acoustics

Mechanical Engineering (n=127) PSU Acoustics Mechanical Engineering (n=127) PSU Acoustics Acoustics Aerospace Engineering (n=31) PSU Aerospace Engineering 0 5 10 15 20 25 30 Aerospace Engineering 0 5 10 15 20 25 30 Agricultural and Resource Economics

More information

NHS ENGLAND BOARD PAPER

NHS ENGLAND BOARD PAPER NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce

More information